A1BJD

3-{[(2S)-1-{[(5P)-3-chloro-5-(1H-imidazol-2-yl)phenyl]amino}-1-oxopropan-2-yl](methyl)carbamoyl}pyridine-2-carboxylic acid

Created:	2024-12-06
Last modified:	2025-01-01

Find Related PDB Entry
1 entries where A1BJD is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	1
Bond Count	50
Aromatic Bond Count	17

2D diagram of A1BJD

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-{[(2S)-1-{[(5P)-3-chloro-5-(1H-imidazol-2-yl)phenyl]amino}-1-oxopropan-2-yl](methyl)carbamoyl}pyridine-2-carboxylic acid
Systematic Name (OpenEye OEToolkits)	3-[[(2~{S})-1-[[3-chloranyl-5-(1~{H}-imidazol-2-yl)phenyl]amino]-1-oxidanylidene-propan-2-yl]-methyl-carbamoyl]pyridine-2-carboxylic acid
Formula	C₂₀ H₁₈ Cl N₅ O₄
Molecular Weight	427.841
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	O=C(O)c1ncccc1C(=O)N(C)C(C)C(=O)Nc1cc(Cl)cc(c1)c1ncc[NH]1
SMILES	CACTVS	3.385	C[CH](N(C)C(=O)c1cccnc1C(O)=O)C(=O)Nc2cc(Cl)cc(c2)c3[nH]ccn3
SMILES	OpenEye OEToolkits	3.1.0.0	CC(C(=O)Nc1cc(cc(c1)Cl)c2[nH]ccn2)N(C)C(=O)c3cccnc3C(=O)O
Canonical SMILES	CACTVS	3.385	C[C@H](N(C)C(=O)c1cccnc1C(O)=O)C(=O)Nc2cc(Cl)cc(c2)c3[nH]ccn3
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	C[C@@H](C(=O)Nc1cc(cc(c1)Cl)c2[nH]ccn2)N(C)C(=O)c3cccnc3C(=O)O
InChI	InChI	1.06	InChI=1S/C20H18ClN5O4/c1-11(26(2)19(28)15-4-3-5-22-16(15)20(29)30)18(27)25-14-9-12(8-13(21)10-14)17-23-6-7-24-17/h3-11H,1-2H3,(H,23,24)(H,25,27)(H,29,30)/t11-/m0/s1
InChIKey	InChI	1.06	NOHBZQQIHRILRX-NSHDSACASA-N

Related Resource References

Resource Name	Reference
PubChem	172639018

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.